Riskpilot← Back to searchSign inGet full accessMedNessity AB
ABActiveOrg 5592210065Anna Steckséns Gata 15 11 TrGeneral medical practice activities · NACE 8621Est. 20190 employees
Revenue 2024
SEK 7,6M
+33% vs 2023
EBITDA margin
76.6%
+63% vs 2023
Equity ratio
64.6%
Financial strength
Net profit 2024
SEK 3,5M
+62% vs 2023
| Revenue | SEK 7,6M | +33% |
| EBITDA | SEK 5,8M | +63% |
| Net profit | SEK 3,5M | +62% |
| Total assets | SEK 12,2M | +53% |
| Equity | SEK 7,9M | +60% |
| Employees | 0 | — |
Legal name
MedNessity AB
Org number
5592210065
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 oktober 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet som stödjer kunder beträffande medicinsk juridiska frågor inom USA och Europa.
Address
Anna Steckséns Gata 15 11 Tr
Email
topmdjd@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 655 | 3 923 | 4 544 | 5 693 | 7 562 |
| Staff expenses | — | — | −1 356 | −1 360 | −1 343 |
| EBITDA | 708 | 2 966 | 2 681 | 3 554 | 5 790 |
| Depreciation & amort. | −0 | −0 | — | — | −112 |
| EBIT | 708 | 2 966 | 2 681 | 3 554 | 5 678 |
| Net financials | — | −1 | −0 | 39 | 176 |
| Profit before tax | 709 | 2 223 | 2 009 | 2 687 | 4 371 |
| Tax | −152 | −459 | −415 | −560 | −916 |
| Net profit | 557 | 1 764 | 1 594 | 2 127 | 3 455 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 247 | 3 339 | 5 430 | 7 976 | 12 172 |
| Equity | 607 | 1 971 | 3 275 | 4 902 | 7 857 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 641 | 625 | 742 | 754 | 513 |
| Total debt | 641 | 625 | 742 | 754 | 513 |
EBITDA margin
76.6%
This company
15.8%
Market median
+385% vs market
20202024
Equity ratio
64.6%
This company
38.2%
Market median
+69% vs market
20202024
Return on equity
44.0%
This company
18.4%
Market median
+139% vs market
20202024
Net profit margin
45.7%
This company
8.1%
Market median
+464% vs market
20202024
Asset turnover
0.62×
This company
1.12×
Market median
-45% vs market
20202024
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2025 | |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2026 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MedNessity AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gerd Veronica Elisabeth Elmgren | Audit | 0 companies |
| Gregory Palega | Board of Directors | 0 companies |
| Lauren Nicole Palega | Deputy Board Member | 0 companies |
| Anna Karolina Lovisa Linnros | Deputy Board Member | 0 companies |